5 Years Development

Income Statement (MEUR)

  IFRS 2022
Continuing operations
IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing
operations
Net sales, (MEUR) *) 82.5 86.9 78.4 75.2 62.8
     Net sales change, % -5.1 10.8 4.2 19.7 21.7
Operating profit/loss, (MEUR) *) 0.3 3.2 2.1 6.3 2.8
     % of net sales 0.4 3.7 2.7 8.4 4.5
Profit / loss for Continuing Operations before taxes, (MEUR) -0.4 2.5 1.6 5.9 2.7
     % of net sales -0.5 2.9 2.1 7.9 4.3
Profit of the year from Continuing Operations, (MEUR) 0.3 3.3 2.2 7.6 4.0
     % of net sales 0.4 3.8 2.8 10.2 6.4
Profit after tax for the year from Discontinued Operations, (MEUR) 0 0 0 0 0
     % of net sales 0 0 0 0 0
Profit for the year attributable to equity holders of the parent, (MEUR) 0.3 3.3 2,2 7.6 4.0
     % of net sales 0.4 3.8 2,8 10.2 6.4

Balance sheet (MEUR)

  IFRS 2022
Continuing operations
IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing operations
Non-current assets 85.0 85.9 86.4 80.5 65.9
Inventories 24.2 18.8 20.9 18.2 14.6
Current assets 60.5  61.4  50.7  55.6 51.9
Assets classified as held for sale          
Sharelolders' equity 115.8 116.8 114.2 112.3 110.0
Non-current liabilities 21.7 21.5 21.9 22.1 1.9
Current liabilities 32.2 27.8 21.8 19.9 20.5
Liabilities classified as held for sale          
Balance sheet total 169.7 166.1 158.0 154.2 132.4

Profitability and Other Key Figures

  IFRS 2022
Continuing operations
IFRS 2021
Continuing operations
IFRS 2020
Continuing operations
IFRS 2019
Continuing operations
IFRS 2018
Continuing operations
Return on equity, % (ROE) 0.2  2.9  1.9  6.9 3.6
Return on investment % (ROI) 0.3  2.3  1.6  5.0 3.7
Interest-bearing net liabilities, (MEUR) 3.4 0.2 -2.1 -12.6 -29.4
Net gearing, % 3.0 0.2 -1.9 -11.2 -26.7
Equity ratio, % 69.7 72.4 73.1 73.4 84.7
Gross investments, (MEUR) *) 9.5 9.6 17.4 21.3 21.2
     Gross investments, % of net sales 11.5 11.0 22.2 28.3 33.8
R&D costs, (MEUR) *) 22.3 19.8 22.8 25.1 21.6
     R&D costs, % of net sales 27.0 22.8 29.1 33.4 34.4
Average personnel during the period, parent and subsidiaries *) 641 664 673 665 660

Stock-Related Financial Ratios

  IFRS 2022 IFRS 2021 IFRS 2020 IFRS 2019 IFRS 2018

Earnings per share from continuing operations, EUR
         
     Basic earnings per share 0.007 0.093 0.061 0.214 0.113
     Diluted earnings per share 0.007 0.093 0.061 0.214 0.113

Earnings per share from discontinued operations, EUR
         
     Basic earnings per share          
     Diluted earnings per share          

Earnings per share from continuing and discontinued operations, EUR
         
     Basic earnings per share 0.007 0.093 0.061 0.214 0.113
     Diluted earnings per share 0.007 0.093 0.061 0.214 0.113
Equity per share, EUR 3.24 3.27 3.2 3.15 3.08
Dividend per share, EUR *) 0.05 0.04 0.0 0.1 0.15
Dividend per earnings, %   44.6 0.0 46.7 132.7
P/E ratio 560.1  56.9  94.9 30.4 67.5
Effective dividend yield, % 0.3  0.8  0.5 0.0 2.0

Market values of shares (EUR)
         
     Highest 6.08 7.89 7.67 8.03 8.1
     Lowest 3.47 4.93 3.40 5.91 4.71
     Average 4.71 6.18 5.74 6.70 5.98
     At the end of period 3.98 5.30 5.79 6.50 7.61
Market value of the stock, (MEUR) 141.9 189.2 206.7 232.0 271.6

Trading value of shares
         
     MEUR 44.0 83.2 117.9 51.5 75.4
     1000 pcs 9 346 13 464 20 557 7 689 12 608
     Related to average number of shares % 26.2 37.7 57.6 21.5 35.3
Adjusted number of the shares at the end of the period (1000 pcs) 35 702 35 700 35 693 35 693 35 693
Adjusted number of the shares average during the period (1000 pcs) 35 702 35 700 35 693 35 693 35 693
Adjusted number of the shares average for the period diluted with stock options (1000 pcs) 35 702 35 700 35 693 35 693 35 693


*) Proposal of the BoD for 2022